Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Urotensin Appears Cardioprotective in End-Stage Renal Disease
Link ID 3797
Title Urotensin Appears Cardioprotective in End-Stage Renal Disease
Url http://www.medscape.com/viewarticle/571039?src=rss
Description Although blockage of urotensin II (UTN) is being investigated as a treatment for heart failure and renal disease, new research suggests that high levels of UTN are actually cardioprotective in patients with end-stage renal disease (ESRD). Reuters Health Information
Category Articles > Nephrology
Keywords
Date Mar 6, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Nephrology
1. Kidney Function and Albuminuria Tied to Mortality
  A reduction in glomerular filtration rate (GFR) and albuminuria are indicative of the risk of cardiovascular and all-cause mortality in the US population, researchers report in the May 15th issue of the American Journal of Epidemiology. Reuters Health Information
Category:   Articles > Nephrology


2. Wearable Hemodialysis Device Shows Promise for End-Stage Renal Failure
  A new wearable hemodialysis device for patients with end-stage renal failure is safe and effective, the findings from a pilot study suggest. The availability of a wearable device could improve the quality of life for these patients who typically must spend a few days each week at a dialysis center. Reuters Health Information
Category:   Articles > Nephrology


3. Prevalence And Severity Of Disordered Mineral Metabolism In Blacks With Chronic Kidney Disease
  Disorders of mineral metabolism develop early in chronic kidney disease, but it appears that Blacks with stage-5 disease have more severe secondary hyperparathyroidism than other races.
Kidney International
Category:   Articles > Nephrology


4. Primum Non Nocere
  It is time for the transplant community to develop a consensus on when the risk to the living donor is justified and when it is not, in relationship to the potential benefits to the recipient.
American Journal of Transplantation
Category:   Articles > Nephrology


5. Angiotensin Receptor Blockers Reduce Cardiovascular Events in Hemodialysis Patients
  Angiotensin receptor blockers (ARBs) reduce cardiovascular events in patients undergoing long-term hemodialysis, according to a report in the September American Journal of Kidney Diseases. Reuters Health Information
Category:   Articles > Nephrology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS